Cannabis Corner: These stocks are all poised for gains

Article Excerpt

First, the good news: widening cannabis legalization will eventually lead to some great business successes. The bad news is that only a few of the multitude of cannabis stocks today will pay off for investors. Consumer cannabis demand is high, but growing and distributing it across multiple markets is more difficult. With “Cannabis Corner,” we focus on quality stocks that are most likely to emerge as winners in the “Wild West” of marijuana investing. CRONOS GROUP, $4.12 (Toronto symbol CRON; TSINetwork Rating: Speculative) (cronosgroup.com; Shares o/s: 375.6 million; Market cap: $1.6 billion; TSI Cannabis Quality Rating [CQR]: ), reports that its revenue jumped 47.6% in the three months ended June 30, 2022, to $23.1 million U.S. from $15.6 million U.S. The increase was primarily driven by continued growth in the adult-use market in Canada and increased sales in the Israeli medical market. Meantime, it holds $944.9 million U.S. in cash, with no debt. That, plus its link to U.S. tobacco giant Altria Group (symbol MO on…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.